Sangamo Therapeutics $SGMO overblown selloff, could bounce high
Look for sustained rally upwards from 50 day average, powerfull buy signal could be triggered and could move the stock closer to its consensus price target of $13.50
https://www.smarteranalyst.com/new-blurbs/sangamo-biosciences-sgmo-gets-a-buy-rating-from-cowen-co/
SGMO
https://investor.sangamo.com/news-releases/news-release-details/sangamo-announces-early-completion-transfer-pfizer-sb-525
https://investor.sangamo.com/news-releases/news-release-details/sangamo-highlights-advancements-genomic-medicine-pipeline-and
https://www.smarteranalyst.com/new-blurbs/sangamo-biosciences-sgmo-gets-a-buy-rating-from-cowen-co/
SGMO
https://investor.sangamo.com/news-releases/news-release-details/sangamo-announces-early-completion-transfer-pfizer-sb-525
https://investor.sangamo.com/news-releases/news-release-details/sangamo-highlights-advancements-genomic-medicine-pipeline-and